Anal Canal Carcinoma — Trials

Anal Canal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

22 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 8
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–9 of 9 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02314169	Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer	active not recruiting	Phase 2	143	National Cancer Institute (NCI)NIH	2	Sep 22, 2026	clinicaltrials
NCT04166318	Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study	active not recruiting	Phase 2	252	ECOG-ACRIN Cancer Research GroupNETWORK	1	Sep 14, 2026	clinicaltrials